Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Traumatic Brain Injury (CRASH-3)
NCT01402882Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2012
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in traumatic brain injury (TBI), sponsored by London School of Hygiene & Tropical Medicine. Started Jul 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01402882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402882.